Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

UNITRON PEG DIN 02242966

Status: Cancelled Post Market
Holder: MERCK CANADA INC
Molecule: PEGINTERFERON ALFA-2B

Health Canada record

Active ingredient(s)PEGINTERFERON ALFA-2B 74 MCG
Dosage formPowder For Solution
RouteSubcutaneous
SchedulePRESCRIPTION; SCHEDULE D
ClassHuman
ATCL03AB10 PEGINTERFERON ALFA-2B
Original market date27-Mar-2001
Current status date01-Feb-2012
SourceHealth Canada DPD

Establishment licence of the holder

Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing PEGINTERFERON ALFA-2B

DINProductCompanyFormStrengthStatus
02242967UNITRON PEGMERCK CANADA INCPowder For SolutionPEGINTERFERON ALFA-2B 118.4 MCGCancelled Post Market
02242968UNITRON PEGMERCK CANADA INCPowder For SolutionPEGINTERFERON ALFA-2B 177.6 MCGCancelled Post Market
02242969UNITRON PEGMERCK CANADA INCPowder For SolutionPEGINTERFERON ALFA-2B 222 MCGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
34852003-01-10Supplement to a New Drug Submission (SNDS)PRODUCT NAME CHANGE FROM PEG-INTRON
13872000-10-20New Drug Submission (NDS)
Request a quote for UNITRON PEG

How to read a Canadian DIN record